脂质过氧化激活在急性甲醇中毒机制中的作用
该研究纳入28例急性甲醇中毒住院患者,并在出院2年后随访36例存活者,采用液相色谱-电喷雾电离串联质谱法测定血清4-羟基-反-2-己烯醛(HHE)、4-羟基壬烯醛(HNE)和丙二醛(MDA)浓度。结果显示三种标志物急性期最大血清浓度均显著高于随访浓度(HNE 71.7±8.0 ng/mL vs 35.4±2.3 ng/mL;HHE 40.1±6.7 ng/mL vs 17.7±4.1 ng/mL;MDA 80.0±7.2 ng/mL vs 40.9±1.9 ng/mL;均p<.001)。无甲醇中毒后遗症的存活者急性期标志物浓度高于有后遗症者。标志物与血清白三烯(LTC4、LTD4、LTE4、LTB4)呈正相关(r=0.608~0.819,均p<.001),与阴离子间隙呈负相关(HNE r=-0.428,p=.026;HHE r=-0.388,p=.045;MDA r=-0.334,p=.080)。出院2年后有或无视觉/神经后遗症的存活者随访标志物浓度无差异。
要点
- 急性甲醇中毒患者急性期血清HNE、HHE、MDA最大浓度显著高于出院2年后随访浓度(均p<.001)。
- 无甲醇中毒后遗症的存活者急性期HNE、HHE、MDA浓度高于有后遗症者。
- HNE、HHE、MDA与血清LTC4、LTD4、LTE4、LTB4均呈正相关(r=0.608~0.819,均p<.001)。
- HNE与阴离子间隙负相关(r=-0.428,p=.026),HHE与阴离子间隙负相关(r=-0.388,p=.045),MDA与阴离子间隙负相关未达统计学显著(r=-0.334,p=.080)。
- 出院2年后有或无视觉/神经后遗症的存活者随访脂质氧化标志物浓度无差异。
适用人群与场景
- 28例急性甲醇中毒住院患者(急性期采血)及其中36例出院2年后存活者(随访采血)。
研究设计与关键结果
- 研究类型:队列研究(急性期与出院2年后随访对照),样本量28例急性甲醇中毒住院患者和36例出院2年后存活者。
- 急性期最大血清浓度 vs 随访浓度:HNE 71.7±8.0 ng/mL vs 35.4±2.3 ng/mL(p<.001);HHE 40.1±6.7 ng/mL vs 17.7±4.1 ng/mL(p<.001);MDA 80.0±7.2 ng/mL vs 40.9±1.9 ng/mL(p<.001)。
- 无甲醇中毒后遗症的存活者急性期血清HNE、HHE、MDA浓度高于有后遗症者。
- HNE与LTC4(r=0.663)、LTD4(r=0.608)、LTE4(r=0.771)、LTB4(r=0.717)相关;HHE与LTC4(r=0.713)、LTD4(r=0.676)、LTE4(r=0.819)、LTB4(r=0.746)相关;MDA与LTC4(r=0.785)、LTD4(r=0.735)、LTE4(r=0.814)、LTB4(r=0.674)相关;均p<.001。
- 脂质过氧化标志物与阴离子间隙相关:HNE r=-0.428(p=.026),HHE r=-0.388(p=.045),MDA r=-0.334(p=.080)。
- 出院2年后有或无视觉/神经后遗症的存活者随访血清脂质氧化标志物浓度无差异。
证据类型、等级与局限
- 证据类型:队列研究(急性期与随访对照)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脂质过氧化在急性甲醇中毒机制中起重要作用。
- 作者认为神经元膜脂质过氧化似乎激活白三烯介导的炎症,作为神经保护机制的一部分。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: The role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning has not been studied.
OBJECTIVE: We measured the concentrations of lipid peroxidation markers in acutely intoxicated patients with known serum concentrations of methanol and leukotrienes.
METHODS: Blood serum samples were collected from 28 patients hospitalized with acute intoxication and from 36 survivors 2 years after discharge. In these samples, concentrations of 4-hydroxy-trans-2-hexenal (HHE), 4-hydroxynonenal (HNE), and malondialdehyde (MDA) were measured using the method of liquid chromatography-electrospray ionization-tandem mass spectrometry.
RESULTS: The maximum acute serum concentrations of all three lipid oxidative damage markers were higher than the follow-up serum concentrations: HNE 71.7 ± 8.0 ng/mL versus 35.4 ± 2.3 ng/mL; p < .001; HHE 40.1 ± 6.7 ng/mL versus 17.7 ± 4.1 ng/mL; p < .001; MDA 80.0 ± 7.2 ng/mL versus 40.9 ± 1.9 ng/mL; p < .001. The survivors without methanol poisoning sequelae demonstrated higher acute serum concentrations of the markers than the patients with sequelae. A correlation between measured markers and serum leukotrienes was present: HNE correlated with LTC4 (r = 0.663), LTD4 (r = 0.608), LTE4 (r = 0.771), LTB4 (r = 0.717), HHE correlated with LTC4 (r = 0.713), LTD4 (r = 0.676), LTE4 (r = 0.819), LTB4 (r = 0.746), MDA correlated with LTC4 (r = 0.785), LTD4 (r = 0.735), LTE4 (r = 0.814), LTB4 (r = 0.674); all p < .001. Lipid peroxidation markers correlated with anion gap (r= -0.428, -0.388, -0.334; p = .026, .045, .080 for HNE, HHE, MDA, respectively). The follow-up serum concentrations of lipid oxidation markers measured in survivors with and without visual/neurological sequelae 2 years after discharge did not differ.
CONCLUSION: Our results demonstrate that lipid peroxidation plays a significant role in the mechanisms of acute methanol poisoning. The acute concentrations of three measured biomarkers were elevated in comparison with the follow-up concentrations. Neuronal membrane lipid peroxidation seems to activate leukotriene-mediated inflammation as a part of the neuroprotective mechanisms. No cases of persistent elevation were registered among the survivors 2 years after discharge.
参考来源
- Hlusicka J, Loster T, Lischkova L, et al. Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning. Clin Toxicol (Phila). 2018. PMID: 29607701. doi:10.1080/15563650.2018.1455980
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。